Product
Pyramax
3 clinical trials
2 indications
Indication
COVID-19Indication
MalariaClinical trial
A Multi-Center Single Arm, Open-label, Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 PatientsStatus: Completed, Estimated PCD: 2022-09-06
Clinical trial
A Multi-center, Randomized, Double-blind, Parallel, Placebo-Controlled, Phase III Clinical Trial to Evaluate Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 PatientsStatus: Completed, Estimated PCD: 2023-03-24
Clinical trial
Open-label, Randomised, Drug Interaction Study of Pyramax (Pyronaridine Artesunate) and the Protease Inhibitor Ritonavir in Healthy VolunteersStatus: Completed, Estimated PCD: 2010-08-01